Related Experiment Videos

Rationale for recombinant human interferon-gamma adjuvant immunotherapy for cancer

H S Jaffe¹, R B Herberman

¹Genetech, Inc., South San Francisco, CA 94080.

Journal of the National Cancer Institute

|July 6, 1988

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2001

A placebo-controlled phase I/II study of adefovir dipivoxil in patients with chronic hepatitis B virus infection.

Journal of viral hepatitis·1999

Clinical pharmacokinetics of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine in human immunodeficiency virus-infected patients.

Antimicrobial agents and chemotherapy·1999

A multicenter phase I/II dose escalation study of single-dose cidofovir gel for treatment of recurrent genital herpes.

Antimicrobial agents and chemotherapy·1998

Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS.

Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1998

The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trial.

The Journal of infectious diseases·1997

See all related articles